Home > PJ (current issue) > The Society / News Centre | Search

The Pharmaceutical Journal
Vol 273 No 7315 p331
4 September 2004


Society summary


Reminder to pharmacists about the 31 December cut-off date for declaration of competence forms for dispensing/pharmacy assistants

The Royal Pharmaceutical Society has issued a reminder to pharmacists about the 31 December cut-off date for submitting declaration of competence forms for each member of staff in current employment who falls within the minimum competence requirement “grandparent” clause.

From 1 January 2005 pharmacists will have a professional obligation to ensure that dispensing/pharmacy assistants are competent in the areas in which they work to a minimum standard equivalent to the new pharmacy services level 2 qualification of the Scottish or National Vocational Qualifications (S/NVQ) or are undertaking training towards achieving such competence. The policy covers dispensing/pharmacy assistants working under the supervision of a pharmacist in the community, hospital or other pharmacy sector.

The transitional arrangements, known as the grandparent clause, will allow existing staff to continue working without the need for a new qualification after 1 January 2005 provided they demonstrate their competence to a satisfactory minimum standard. Supervising pharmacists must complete a declaration of competence form for each member of staff whom they wish to declare as exempt from further training. Any employee who has not been declared exempt from further training under the grandparent clause arrangements will, from 1 January 2005, be required to undertake an accredited course.

Further information on the regulation of dispensing/pharmacy assistants, including copies of the declaration of competence form, a list of approved courses (mapped for equivalence under the grandparent clause arrangements), frequently-asked questions and case studies, can be obtained from
the Society’s website (www.rpsgb.org/pharmacysupportstaff). Copies of the declaration of competence form can also be requested from the Society’s Registration Section (telephone 020 7572 2577 or e-mail: gp2@rpsgb.org).

Further information is also available from Sadia Khan at the Society’s headquarters on (tel 020 7572 2537; e-mail sadia.khan@rpsgb. org)

Back to Top


©The Pharmaceutical Journal